Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Between 2004 and 2014, African-American women in South Carolina were less likely to receive guideline-based treatment.
The committee voted against third shot for all adults, however, casting doubts on Biden’s booster plan.
An HIV-specific model underestimated the risk for heart attacks and other cardiovascular events.
Two-drug combo of dolutegravir and lamivudine suppresses HIV in newly diagnosed people.
Sometimes the older formulation of tenofovir is a better choice for HIV prevention.
People who received a higher dose had stronger and longer-lasting immune responses.
People living with HIV in the U.K. had a much higher risk for heart disease, regardless of age or when they were diagnosed.
Disparities in who gets a PrEP prescription and who doesn’t show up even among those with access to care.
Study of cisgender men living with HIV found strong associations with some common health conditions.
Some men living with HIV still practice serosorting, but HIV-negative men on PrEP often were more likely to have HIV-positive partners.
Whether or not they want kids, access to accurate information and the tools to conceive—or not—are essential for people living with HIV.
Full approval could encourage more people to get vaccinated and raises the prospect of off-label use.
People who switched to such a regimen gained up to 10 pounds in nine months.
The booster is recommended for organ transplant recipients, people receiving cancer treatment and people with advanced or untreated HIV.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.